Disruption of heme homeostasis by nuclear receptor Nur77 induces pyroptosis through granzyme B-dependent GSDMC cleavage
8.0
来源：
Nature
关键字：
mRNA
发布时间：
2025-12-18 03:46
摘要：
DdBIC is identified as a novel compound that induces pyroptosis in melanoma cells through the nuclear receptor Nur77, disrupting heme homeostasis and activating granzyme B-dependent GSDMC cleavage. This mechanism provides a new therapeutic strategy for treating melanoma, particularly in apoptosis-resistant cases. The study demonstrates DdBIC's potential in vivo, showing significant tumor growth inhibition in mouse models without notable side effects, indicating its promising translational potential in oncology.
原文：
查看原文
价值分投票
评分标准
新闻价值分采用0-10分制，综合考虑新闻的真实性、重要性、时效性、影响力等多个维度。
评分越高，表示该新闻的价值越大，越值得关注。
价值维度分析
domain_focus
1.0分+1.0分（符合肿瘤学领域）
business_impact
1.0分+1.0分（可能影响癌症治疗市场）
scientific_rigor
1.5分+1.5分（有具体实验数据和机制阐述）
timeliness_innovation
1.5分+1.5分（提供新的治疗策略和机制）
investment_perspective
2.5分+2.5分（早期研发阶段，具有投资潜力）
market_value_relevance
1.0分+1.0分（针对高发疾病）
team_institution_background
0.5分+0.5分（研究团队背景强）
technical_barrier_competition
1.0分+1.0分（技术壁垒高，竞争少）
关键证据
DdBIC induces GSDMC-mediated pyroptosis in melanoma cells.
The study elucidates a novel mechanism involving Nur77 and heme metabolism.
DdBIC shows significant antitumor effects in mouse models.
真实性检查
否
AI评分总结
DdBIC is identified as a novel compound that induces pyroptosis in melanoma cells through the nuclear receptor Nur77, disrupting heme homeostasis and activating granzyme B-dependent GSDMC cleavage. This mechanism provides a new therapeutic strategy for treating melanoma, particularly in apoptosis-resistant cases. The study demonstrates DdBIC's potential in vivo, showing significant tumor growth inhibition in mouse models without notable side effects, indicating its promising translational potential in oncology.